The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses
Open accessPublished version of a preprint
Abstract
Over the past 20 years, several coronaviruses have crossed the species barrier into humans, causing outbreaks of severe, and often fatal, respiratory illness. Since SARS-CoV was first identified in animal markets, global viromics projects have discovered thousands of coronavirus sequences in diverse animals and geographic regions. Unfortunately, there are few tools available to functionally test these viruses for their ability to infect humans, which has severely hampered efforts to predict the next zoonotic viral outbreak. Here, we developed an approach to rapidly screen lineage B betacoronaviruses, such as SARS-CoV and the recent SARS-CoV-2, for receptor usage and their ability to infect cell types from different species. We show that host protease processing during viral entry is a significant barrier for several lineage B viruses and that bypassing this barrier allows several lineage B viruses to enter human cells through an unknown receptor. We also demonstrate how different lineage B viruses can recombine to gain entry into human cells, and confirm that human ACE2 is the receptor for the recently emerging SARS-CoV-2.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The S protein mediates binding of coronaviruses to angiotensin converting enzyme 2 (ACE2) on the surface of various cell types including epithelial cells of the pulmonary alveolus (4–6).”
From An Alphavirus -derived replicon RNA vaccine induces SARS-CoV-2 neutralizing antibody and T cell responses in mice and nonhuman primates (2020) · cites this paper as [5]
Experimental — accuracy not yet measuredIn the citing paper
“it directly interacts with the cellular receptor angiotensin converting enzyme 2 (ACE2) which mediates host cell entry”
From SARS-CoV-2 mRNA vaccination induces functionally diverse antibodies to NTD, RBD, and S2 (2021) · cites this paper as Letko et al., 2020
In the citing paper
“SARS-CoV-2 is a single-stranded RNA β-coronavirus and a member of the subgenus Sarbecovirus (beta-CoV lineage B).”
From Oral Microbiome and SARS-CoV-2: Beware of Lung Co-infection (2020) · cites this paper as Letko et al., 2020
In the citing paper
“It is the seventh member of the Coronaviridae known to infect humans so far, two of which, SARS-CoV and MERS-CoV, caused global health threats previously (Guarner, 2020; Letko et al., 2020).”
From Oral Microbiome and SARS-CoV-2: Beware of Lung Co-infection (2020) · cites this paper as Letko et al., 2020
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A pneumonia outbreak associated with a new coronavirus of probable bat origin
Zhou, P., Yang, X.-L., Wang, X.-G., Hu, B., Zhang, L., Zhang, W., Si, H.-R., Zhu, Y., Li, B., Huang, C.-L., et al. (2020) · Nature · doi:10.1038/s41586-020-2012-7 · Cited by 21,969
Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus
Li, W., Moore, M. J., Vasilieva, N., Sui, J., Wong, S. K., Berne, M. A., Somasundaran, M., Sullivan, J. L., Luzuriaga, K., Greenough, T. C., et al. (2003) · Nature · doi:10.1038/nature02145 · Cited by 5,923
Wan, Y., Shang, J., Graham, R., Baric, R. S., & Li, F. (2020) · Journal of Virology · doi:10.1128/jvi.00127-20 · Cited by 4,341
Structure, Function, and Evolution of Coronavirus Spike Proteins
Li, F. (2016) · Annual Review of Virology · doi:10.1146/annurev-virology-110615-042301 · Cited by 2,740
Bats Are Natural Reservoirs of SARS-Like Coronaviruses
Li, W., Shi, Z., Yu, M., Ren, W., Smith, C. S., Epstein, J. H., Wang, H., Crameri, G. S., Hú, Z., Zhang, H., et al. (2005) · Science · doi:10.1126/science.1118391 · Cited by 2,571
Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC
Raj, V. S., Mou, H., Smits, S. L., Dekkers, D. H. W., Müller, M. A., Dijkman, R., Muth, D., Demmers, J. A. A., Zaki, A., Fouchier, R. A. M., et al. (2013) · Nature · doi:10.1038/nature12005 · Cited by 2,061
Structure of SARS Coronavirus Spike Receptor-Binding Domain Complexed with Receptor
Li, F., Li, W., Farzan, M., & Harrison, S. C. (2005) · Science · doi:10.1126/science.1116480 · Cited by 2,035
Isolation and characterization of a bat SARS-like coronavirus that uses the ACE2 receptor
Ge, X.-Y., Li, J.-L., Yang, X.-L., Chmura, A. A., Zhu, G., Epstein, J. H., Mazet, J. K., Hu, B., Zhang, W., Peng, C., et al. (2013) · Nature · doi:10.1038/nature12711 · Cited by 1,778
Severe acute respiratory syndrome coronavirus-like virus in Chinese horseshoe bats
Lau, S. K. P., Woo, P. C. Y., Li, K. S. M., Huang, Y. P., Tsoi, H., Wong, B. H. L., Wong, S. S. Y., Leung, S.-Y., Chan, K., & Yuen, K. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506735102 · Cited by 1,561
Belouzard, S., Chu, V. C., & Whittaker, G. R. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0809524106 · Cited by 1,076
Cited by
Sorted by citations
Items 401–500 of 1,005
The future of zoonotic risk prediction
Carlson, C. J., Farrell, M. J., Grange, Z., Han, B. A., Mollentze, N., Phelan, A., Rasmussen, A. L., Albery, G. F., Bett, B., Brett‐Major, D. M., et al. (2021) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2020.0358 · Cited by 102
Damas, J., Hughes, G. M., Keough, K. C., Painter, C., Persky, N. S., Corbo, M., Hiller, M., Koepfli, K., Pfenning, A. R., Zhao, H., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.04.16.045302 · Cited by 98
Jung, F., Krüger‐Genge, A., Franke, R. P., Hufert, F. T., & Küpper, J. ‐. (2020) · Clinical Hemorheology and Microcirculation · doi:10.3233/ch-209007 · Cited by 97
Rossi, G. A., Sacco, O., Mancino, E., Cristiani, L., & Midulla, F. (2020) · Infection · doi:10.1007/s15010-020-01486-5 · Cited by 102
Elekofehinti, O. O., Iwaloye, O., Josiah, S. S., Lawal, A. O., Akinjiyan, M. O., & Ariyo, E. O. (2020) · Molecular Diversity · doi:10.1007/s11030-020-10151-w · Cited by 100
The potential of glycyrrhizin and licorice extract in combating COVID-19 and associated conditions
Gomaa, A. A., & Abdel-Wadood, Y. A. (2021) · Phytomedicine Plus · doi:10.1016/j.phyplu.2021.100043 · Cited by 101
COVID-19 Deaths: Are We Sure It Is Pneumonia? Please, Autopsy, Autopsy, Autopsy!
Pomara, C., Volti, G. L., & Cappello, F. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9051259 · Cited by 101
Pollet, J. B. K., Chen, W., Versteeg, L., Keegan, B. P., Zhan, B., Wei, J., Liu, Z., Lee, J., Kundu, R., Adhikari, R., et al. (2021) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2021.1901545 · Cited by 94
Revzin, M. V., Raza, S., Warshawsky, R., D’Agostino, C. A., Srivastava, N. C., Bader, A. S., Malhotra, A., Patel, R. D., Chen, K., Kyriakakos, C., et al. (2020) · Radiographics · doi:10.1148/rg.2020200149 · Cited by 103
Replication, pathogenicity, and transmission of SARS-CoV-2 in minks
Shuai, L., Zhong, G., Yuan, Q., Wen, Z., Wang, C., He, X., Liu, R., Wang, J., Zhao, Q., Liu, Y., et al. (2020) · National Science Review · doi:10.1093/nsr/nwaa291 · Cited by 98
Pickering, B., Smith, G. C., Pinette, M. M., Embury‐Hyatt, C., Moffat, E., Marszal, P., & Lewis, C. E. (2020) · Emerging infectious diseases · doi:10.3201/eid2701.203399 · Cited by 95
Application of Nanotechnology in the COVID-19 Pandemic
Yang, D. (2021) · International Journal of Nanomedicine · doi:10.2147/ijn.s296383 · Cited by 99
Gut microbiota and renin-angiotensin system: a complex interplay at local and systemic levels
Jaworska, K., Koper, M., & Ufnal, M. (2021) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00099.2021 · Cited by 93
Oral Nirmatrelvir/Ritonavir Therapy for COVID-19: The Dawn in the Dark?
Hung, Y., Lee, J., Chiu, C.-W., Lee, C., Tsai, P.-J., Hsu, I.-L., & Ko, W. (2022) · Antibiotics · doi:10.3390/antibiotics11020220 · Cited by 95
RNA G-quadruplex in TMPRSS2 reduces SARS-CoV-2 infection
Liu, G., Du, W., Sang, X., Tong, Q., Wang, Y., Chen, G., Yuan, Y., Jiang, L., Cheng, W., Liu, D., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-29135-5 · Cited by 98
Ballout, R. A., Sviridov, D., Bukrinsky, M., & Remaley, A. T. (2020) · The FASEB Journal · doi:10.1096/fj.202000654r · Cited by 91
Park, S. E. (2020) · Pediatric Infection & Vaccine · doi:10.14776/piv.2020.27.e9 · Cited by 102
Yao, Y., Wang, H., & Liu, Z. (2020) · Clinical & Experimental Allergy · doi:10.1111/cea.13746 · Cited by 93
Atlas of ACE2 gene expression reveals novel insights into transmission of SARS-CoV-2
Sun, K., Gu, L., Ma, L., & Duan, Y. (2020) · Heliyon · doi:10.1016/j.heliyon.2020.e05850 · Cited by 97
Song, J., Lu, C. T., Leszek, J., & Zhang, J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221810118 · Cited by 97
Bibliometric analysis of global scientific research on Coronavirus (COVID-19)
Dehghanbanadaki, H., Seif, F., Vahidi, Y., Razi, F., Hashemi, E., Khoshmirsafa, M., & Aazami, H. (2020) · Medical Journal of the Islamic Republic of Iran · doi:10.47176/mjiri.34.51 · Cited by 122
Immune recall improves antibody durability and breadth to SARS-CoV-2 variants
Chen, Y., Tong, P., Whiteman, N. B., Moghaddam, A. S., Zarghami, M., Zuiani, A., Habibi, S., Gautam, A. K., Keerti, K., Bi, C., et al. (2022) · Science Immunology · doi:10.1126/sciimmunol.abp8328 · Cited by 89
Viral Membrane Fusion: A Dance Between Proteins and Lipids
White, J. M., Ward, A. E., Odongo, L., & Tamm, L. K. (2023) · Annual Review of Virology · doi:10.1146/annurev-virology-111821-093413 · Cited by 99
COVID-19: neonatal–perinatal perspectives
On behalf of the Harvard Neonatal-Perinatal Fellowship COVID-19 Working Group, Barrero-Castillero, A., Beam, K. S., Bernardini, L. B., Ramos, E. G. C., Davenport, P. E., Duncan, A. R., Fraiman, Y. S., Frazer, L. C., Healy, H., et al. (2021) · Journal of Perinatology · doi:10.1038/s41372-020-00874-x · Cited by 92
Origin, Potential Therapeutic Targets and Treatment for Coronavirus Disease (COVID-19)
Nadeem, M. S., Zamzami, M. A., Choudhry, H., Murtaza, B. N., Kazmi, I. A., Ahmad, H., & Shakoori, A. R. (2020) · Pathogens · doi:10.3390/pathogens9040307 · Cited by 95
Troyer, Z., Alhusaini, N., Tabler, C. O., Sweet, T. J., Carvalho, K. I., Schlatzer, D., Carias, L. L., King, C. L., Matreyek, K. A., & Tilton, J. C. (2021) · Journal of Extracellular Vesicles · doi:10.1002/jev2.12112 · Cited by 90
Conformational dynamics and allosteric modulation of the SARS-CoV-2 spike
Díaz-Salinas, M. A., Li, Q., Ejemel, M., Yurkovetskiy, L., Luban, J., Shen, K., Wang, Y., & Munro, J. B. (2022) · eLife · doi:10.7554/elife.75433 · Cited by 81
Kosidło, J. W., Wolszczak-Biedrzycka, B., Matowicka-Karna, J., Dymicka-Piekarska, V., & Dorf, J. (2023) · Journal of Inflammation Research · doi:10.2147/jir.s395331 · Cited by 93
Cardiac inflammation in COVID-19: Lessons from heart failure
Unudurthi, S. D., Luthra, P., Bose, R. J., McCarthy, J. R., & Kontaridis, M. I. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118482 · Cited by 94
Impact of COPD on COVID-19 prognosis: A nationwide population-based study in South Korea
Lee, S. C., Son, K. J., Han, C. H., Park, S. C., & Jung, J. Y. (2021) · Scientific Reports · doi:10.1038/s41598-021-83226-9 · Cited by 92
Harbison, A. M., Fogarty, C. A., Phung, T. K., Satheesan, A., Schulz, B. L., & Fadda, E. (2021) · Chemical Science · doi:10.1039/d1sc04832e · Cited by 86
Maria, E. D., Latini, A., Borgiani, P., & Novelli, G. (2020) · Human Genomics · doi:10.1186/s40246-020-00280-6 · Cited by 93
The evolutionary history of ACE2 usage within the coronavirus subgenus Sarbecovirus
Wells, H., Letko, M. C., Lasso, G., Ssebide, B., Nziza, J., Byarugaba, D. K., Navarrete‐Macias, I., Liang, E., Cranfield, M. R., Han, B. A., et al. (2021) · Virus Evolution · doi:10.1093/ve/veab007 · Cited by 97
Self-citationInfection and transmission of SARS‐CoV‐2 depend on heparan sulfate proteoglycans
Bermejo‐Jambrina, M., Eder, J., Kaptein, T. M., van Hamme, J. L., Helgers, L. C., Vlaming, K. E., Brouwer, P. J. M., Vlaar, A. P. J., van Baarle, F. L. F., Spaargaren, M., et al. (2021) · The EMBO Journal · doi:10.15252/embj.2020106765 · Cited by 88
Keyhan, S. O., Fallahi, H. R., & Cheshmi, B. (2020) · Maxillofacial Plastic and Reconstructive Surgery · doi:10.1186/s40902-020-00254-7 · Cited by 93
Lokman, S. M., Rasheduzzaman, M., Salauddin, A., Barua, R., Tanzina, A. Y., Rumi, M. H., Hossain, M. I., Siddiki, A. Z., Mannan, A., & Hasan, M. M. (2020) · Infection Genetics and Evolution · doi:10.1016/j.meegid.2020.104389 · Cited by 90
Ashhurst, A. S., Tang, A. H., Fajtová, P., Yoon, M. C., Aggarwal, A., Bedding, M. J., Stoye, A., Beretta, L., Pwee, D., Drelich, A. K., et al. (2021) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.1c01494 · Cited by 95
Engineered ACE2 decoy mitigates lung injury and death induced by SARS-CoV-2 variants
Zhang, L., Dutta, S., Xiong, S., Chan, M. C., Chan, K. K., Fan, T. M., Bailey, K. L., Lindeblad, M. O., Cooper, L. M., Rong, L., et al. (2022) · Nature Chemical Biology · doi:10.1038/s41589-021-00965-6 · Cited by 87
Sencio, V., Machelart, A., Robil, C., Benech, N., Hoffmann, E., Galbert, C., Deryuter, L., Heumel, S., Hantute-Ghesquier, A., Flourens, A., et al. (2021) · Gut Microbes · doi:10.1080/19490976.2021.2018900 · Cited by 90
Buhre, J. S., Pongrácz, T., Künsting, I., Lixenfeld, A. S., Wang, W., Nouta, J., Lehrian, S., Schmelter, F., Lunding, H. B., Dühring, L., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1020844 · Cited by 90
Vasculopathy and Coagulopathy Associated with SARS-CoV-2 Infection
Labò, N., Ohnuki, H., & Tosato, G. (2020) · Cells · doi:10.3390/cells9071583 · Cited by 92
Obesity is a potential risk factor contributing to clinical manifestations of COVID-19
Kang, Z., Luo, S., Yang, G., Zhou, H., Zhang, Z., Tian, C., Zhou, Q., Wang, Q., Hu, Y., Fan, H., et al. (2020) · International Journal of Obesity · doi:10.1038/s41366-020-00677-2 · Cited by 89
Villoutreix, B. O., Cálvez, V., Marcelin, A., & Khatib, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22041695 · Cited by 89
Predicting the zoonotic capacity of mammals to transmit SARS-CoV-2
Fischhoff, I. R., Castellanos, A. A., Rodrigues, J., Varsani, A., & Han, B. A. (2021) · Proceedings of the Royal Society B Biological Sciences · doi:10.1098/rspb.2021.1651 · Cited by 90
The origins of COVID‐19 pandemic: A brief overview
Hao, Y., Wang, Y., Wang, M.-Y., Zhou, L., Shi, J., Cao, J., & Wang, D. (2022) · Transboundary and Emerging Diseases · doi:10.1111/tbed.14732 · Cited by 139
Guo, L., Lin, S., Chen, Z., Cao, Y., He, B., & Lu, G. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01472-x · Cited by 90
Rationally Designed ACE2-Derived Peptides Inhibit SARS-CoV-2
Larue, R. C., Xing, E., Kenney, A. D., Zhang, Y., Tuazon, J. A., Lǐ, J., Yount, J. S., Li, P., & Sharma, A. (2020) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.0c00664 · Cited by 86
The Mucosal and Serological Immune Responses to the Novel Coronavirus (SARS-CoV-2) Vaccines
Chan, R. W. Y., Liu, S., Cheung, J. Y., Tsun, J. G., Chan, K. C. C., Chan, K. Y. Y., Fung, G. P. G., Li, A. M., & Lam, H. S. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.744887 · Cited by 86
Boosting with variant-matched or historical mRNA vaccines protects against Omicron infection in mice
Ying, B., Scheaffer, S. M., Whitener, B. M., Liang, C.-Y., Dmytrenko, O., Mackin, S., Wu, K., Lee, D. W., Avena, L. E., Chong, Z., et al. (2022) · Cell · doi:10.1016/j.cell.2022.03.037 · Cited by 109
Phytogenic Products and Phytochemicals as a Candidate Strategy to Improve Tolerance to Coronavirus
Attia, Y. A., Alagawany, M. M., Farag, M. R., Alkhatib, F., Khafaga, A. F., Abdel‐Moneim, A. E., Asiry, K. A., Mesalam, N. M., Shafi, M. E., Al‐Harthi, M. A., et al. (2020) · Frontiers in Veterinary Science · doi:10.3389/fvets.2020.573159 · Cited by 87
Current State of the First COVID-19 Vaccines
Prüβ, B. M. (2021) · Vaccines · doi:10.3390/vaccines9010030 · Cited by 90
Imiquimod - A toll like receptor 7 agonist - Is an ideal option for management of COVID 19
Angelopoulou, A., Alexandris, N., Konstantinou, E. K., Mesiakaris, K., Zanidis, C., Farsalinos, K. E., & Poulas, K. A. (2020) · Environmental Research · doi:10.1016/j.envres.2020.109858 · Cited by 86
Lubbe, L., Cozier, G. E., Oosthuizen, D., Acharya, K. R., & Sturrock, E. D. (2020) · Clinical Science · doi:10.1042/cs20200899 · Cited by 93
A structural view of the SARS-CoV-2 virus and its assembly
Hardenbrook, N. J., & Zhang, P. (2021) · Current Opinion in Virology · doi:10.1016/j.coviro.2021.11.011 · Cited by 93
Zheng, Z., Monteil, V., Maurer‐Stroh, S., Yew, C. W., Leong, C., Mohd-Ismail, N. K., Arularasu, S. C., Chow, V. T. K., Lin, R. T. P., Mirazimi, A., et al. (2020) · Eurosurveillance · doi:10.2807/1560-7917.es.2020.25.28.2000291 · Cited by 82
Is diabetes mellitus a risk factor for COronaVIrus Disease 19 (COVID-19)?
Pugliese, G., Vitale, M., Resi, V., & Orsi, E. (2020) · Acta Diabetologica · doi:10.1007/s00592-020-01586-6 · Cited by 89
SARS-CoV-2 and Risk to Food Safety
Anelich, L. E., Lues, R. J. F., Farber, J. M., & Parreira, V. R. (2020) · Frontiers in Nutrition · doi:10.3389/fnut.2020.580551 · Cited by 86
Research Progress on the Antiviral Activity of Glycyrrhizin and its Derivatives in Liquorice
Huan, C., Xu, Y. Q., Zhang, W., Guo, T., Pan, H., & Gao, S. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.680674 · Cited by 88
Adenoviral Vector-Based Vaccine Platform for COVID-19: Current Status
Chavda, V. P., Bezbaruah, R., Valu, D., Patel, B., Kumar, A., Prasad, S. K., Kakoti, B. B., Kaushik, A. K., & Jesawadawala, M. (2023) · Vaccines · doi:10.3390/vaccines11020432 · Cited by 88
D'Souza, R. D., Malhamé, I., Teshler, L., Acharya, G., Hunt, B. J., & McLintock, C. (2020) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.1111/aogs.13962 · Cited by 84
A Message from the Human Placenta: Structural and Immunomodulatory Defense against SARS-CoV-2
Kreis, N., Ritter, A., Louwen, F., & Yuan, J. (2020) · Cells · doi:10.3390/cells9081777 · Cited by 83
The roles of signaling pathways in SARS-CoV-2 infection; lessons learned from SARS-CoV and MERS-CoV
Hemmat, N., Asadzadeh, Z., Ahangar, N. K., Alemohammad, H., Najafzadeh, B., Derakhshani, A., Baghbanzadeh, A., Baghi, H. B., Javadrashid, D., Najafi, S., et al. (2021) · Archives of Virology · doi:10.1007/s00705-021-04958-7 · Cited by 81
Amanat, F., Strohmeier, S., Rathnasinghe, R., Schotsaert, M., Coughlan, L., García‐Sastre, A., & Krammer, F. (2021) · mBio · doi:10.1128/mbio.02648-20 · Cited by 86
Yu, J., Li, Z., He, X., Gebre, M. S., Bondzie, E. A., Wan, H., Jacob-Dolan, C., Martinez, D. R., Nkolola, J. P., Baric, R. S., et al. (2021) · Journal of Virology · doi:10.1128/jvi.00044-21 · Cited by 85
Sequence signatures of two public antibody clonotypes that bind SARS-CoV-2 receptor binding domain
Tan, T. J. C., Yuan, M., Kuzelka, K., Padron, G. C., Beal, J. R., Chen, X., Wang, Y., Rivera-Cardona, J., Zhu, X., Stadtmueller, B. M., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-24123-7 · Cited by 75
The Potential of Antiviral Peptides as COVID-19 Therapeutics
Mahendran, A. S. K., Lim, Y. S., Fang, C.-M., Loh, H., & Le, C. F. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.575444 · Cited by 82
Outlaw, V. K., Bovier, F. T., Mears, M. C., Cajimat, M. N. B., Zhu, Y., Lin, M. J., Addetia, A., Lieberman, N. A. P., Peddu, V., Xie, X., et al. (2020) · mBio · doi:10.1128/mbio.01935-20 · Cited by 82
Shah, M., Ahmad, B., Choi, S., & Woo, H. G. (2020) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2020.11.002 · Cited by 79
Protein-based lateral flow assays for COVID-19 detection
Mahmoudinobar, F., Britton, D., & Montclare, J. K. (2021) · Protein Engineering Design and Selection · doi:10.1093/protein/gzab010 · Cited by 82
Glycosylation of SARS-CoV-2: structural and functional insights
Shajahan, A., Pepi, L. E., Rouhani, D. S., Heiß, C., & Azadi, P. (2021) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-021-03499-x · Cited by 83
Covid-19 and Pregnancy: An Overview
Castro, P., Matos, A. P. P., Werner, H., Lopes, F. P. P. L., Tonni, G., & Júnior, E. A. (2020) · Revista Brasileira Ginecologia e Obstetrícia · doi:10.1055/s-0040-1713408 · Cited by 83
Boban, M. (2020) · International Journal of Clinical Practice · doi:10.1111/ijcp.13868 · Cited by 80
The impact of SARS-CoV-2 and COVID-19 on male reproduction and men’s health
Patel, D. P., Punjani, N., Guo, J., Alukal, J. P., Li, P. S., & Hotaling, J. M. (2021) · Fertility and Sterility · doi:10.1016/j.fertnstert.2020.12.033 · Cited by 83
Oguntuyo, K. Y., Stevens, C. S., Hung, C.-T., Ikegame, S., Acklin, J. A., Kowdle, S., Carmichael, J. C., Chiu, H.-P., Azarm, K. D., Haas, G. D., et al. (2021) · mBio · doi:10.1128/mbio.02492-20 · Cited by 73
Choi, Y. K., Cao, Y., Frank, M., Woo, H., Park, S., Yeom, M. S., Croll, T. I., Seok, C., & Im, W. (2021) · Journal of Chemical Theory and Computation · doi:10.1021/acs.jctc.0c01144 · Cited by 78
Diabetes and COVID-19; A Bidirectional Interplay
Kazakou, P., Lambadiari, V., Ikonomidis, I., Kountouri, A., Panagopoulos, G. N., Athanasopoulos, S., Korompoki, E., Kalomenidis, I., Dimopoulos, M. A., & Mitrakou, A. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.780663 · Cited by 90
Jamison, D. A., Narayanan, S. A., Trovão, N. S., Guarnieri, J. W., Topper, M. J., Moraes‐Vieira, P. M., Zaksas, V., Singh, K. K., Wurtele, E. S., & Beheshti, A. (2022) · European Journal of Human Genetics · doi:10.1038/s41431-022-01108-8 · Cited by 95
SARS-CoV-2 Spike triggers barrier dysfunction and vascular leak via integrins and TGF-β signaling
Biering, S. B., de Sousa, F. T. G., Tjang, L. V., Pahmeier, F., Zhu, C., Ruan, R., Blanc, S. F., Patel, T. S., Worthington, C. M., Glasner, D. R., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-34910-5 · Cited by 92
Shah, H., Khan, M. S. H., Dhurandhar, N. V., & Hegde, V. (2021) · Acta Diabetologica · doi:10.1007/s00592-020-01636-z · Cited by 80
Fight against novel coronavirus: A perspective of medicinal chemists
Amin, S. A., & Jha, T. (2020) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2020.112559 · Cited by 83
Hirotsu, Y., Mochizuki, H., & Omata, M. (2020) · Journal of Virological Methods · doi:10.1016/j.jviromet.2020.113926 · Cited by 80
The Impact of SARS-Cov-2 Virus Infection on the Endocrine System
Somasundaram, N. P., Ranathunga, I., Ratnasamy, V., Wijewickrama, P. S. A., Dissanayake, H. A., Yogendranathan, N., Gamage, K. K. K., de Silva, N. L., Sumanatilleke, M., Katulanda, P., et al. (2020) · Journal of the Endocrine Society · doi:10.1210/jendso/bvaa082 · Cited by 84
Maio, F. D., Cascio, E. L., Babini, G., Sali, M., Longa, S. D., Tilocca, B., Roncada, P., Arcovito, A., Sanguinetti, M., Scambia, G., et al. (2020) · Microbes and Infection · doi:10.1016/j.micinf.2020.08.006 · Cited by 80
Assessing Antigen Structural Integrity through Glycosylation Analysis of the SARS-CoV-2 Viral Spike
Brun, J., Vasiljević, S., Gangadharan, B., Hensen, M., Chandran, A. V., Hill, M. L., Kiappes, J. L., Dwek, R. A., Alonzi, D. S., Struwe, W. B., et al. (2021) · ACS Central Science · doi:10.1021/acscentsci.1c00058 · Cited by 92
A review on potential of natural products in the management of COVID-19
Chakravarti, R., Singh, R., Ghosh, A., Dey, D., Sharma, P., Ravichandiran, V., Roy, S., & Ghosh, D. (2021) · RSC Advances · doi:10.1039/d1ra00644d · Cited by 81
Chen, C., Boorla, V. S., Banerjee, D., Chowdhury, R., Cavener, V. S., Nissly, R. H., Gontu, A., Boyle, N. R., Vandegrift, K. J., Nair, M. S., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2106480118 · Cited by 81
COVID-19 in Human, Animal, and Environment: A Review
Swelum, A. A., Shafi, M. E., Albaqami, N. M., El‐Saadony, M. T., Elsify, A. M., Abdo, M., Taha, A. E.-S., Abdel‐Moneim, A. E., Al-Gabri, N. A., Almaiman, A. A., et al. (2020) · Frontiers in Veterinary Science · doi:10.3389/fvets.2020.00578 · Cited by 83
Increased small particle aerosol transmission of B.1.1.7 compared with SARS-CoV-2 lineage A in vivo
Port, J. R., Yinda, C. K., Avanzato, V. A., Schulz, J. E., Holbrook, M. G., van Doremalen, N., Shaia, C., Fischer, R. J., & Munster, V. J. (2022) · Nature Microbiology · doi:10.1038/s41564-021-01047-y · Cited by 77
Self-citationStructural dynamics in the evolution of SARS-CoV-2 spike glycoprotein
Calvaresi, V., Wrobel, A. G., Toporowska, J., Hammerschmid, D., Doores, K. J., Bradshaw, R. T., Parsons, R. B., Benton, D. J., Roustan, C., Reading, E., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-36745-0 · Cited by 81
Tackling COVID-19 with neutralizing monoclonal antibodies
Corti, D., Purcell, L. A., Snell, G., & Veesler, D. (2021) · Cell · doi:10.1016/j.cell.2021.07.027 · Cited by 78
“All mAbs authorized or in development are directed to the RBD, which interacts with the target receptor angiotensin-converting enzyme 2 (ACE2) (Hoffmann et al., 2020; Letko et al., 2020; Walls et al., 2020b; Zhou et al., 2020).”
TINJAUAN PUSTAKA COVID-19: VIROLOGI, PATOGENESIS, DAN MANIFESTASI KLINIS
Fitriani, N. I. (2021) · Jurnal Medika Malahayati · doi:10.33024/jmm.v4i3.3174 · Cited by 78
Replication and single-cycle delivery of SARS-CoV-2 replicons
Ricardo-Lax, I., Luna, J. M., Thao, T. T. N., Pen, J. L., Yu, Y., Hoffmann, H.-H., Schneider, W. M., Razooky, B. S., Fernández-Martínez, J., Schmidt, F., et al. (2021) · Science · doi:10.1126/science.abj8430 · Cited by 80
A Systematic Review of COVID-19 and Myocarditis
Kariyanna, P. T., Sutarjono, B., Grewal, E., Singh, K. P., Aurora, L., Smith, L., Chandrakumar, H. P., Jayarangaiah, A., Goldman, S. A., Salifu, M. O., et al. (2020) · American Journal of Medical Case Reports · doi:10.12691/ajmcr-8-9-11 · Cited by 77
Role of the early secretory pathway in SARS-CoV-2 infection
Sicari, D., Chatziioannou, A. A., Koutsandreas, T., Sitia, R., & Chevet, É. (2020) · The Journal of Cell Biology · doi:10.1083/jcb.202006005 · Cited by 76
Analysis of ACE2 genetic variants in 131 Italian SARS-CoV-2-positive patients
Novelli, A., Biancolella, M., Borgiani, P., Cocciadiferro, D., Colona, V. L., D’Apice, M. R., Rogliani, P., Zaffina, S., Leonardis, F., Campana, A., et al. (2020) · Human Genomics · doi:10.1186/s40246-020-00279-z · Cited by 76
Bowen, J. E., Park, Y., Stewart, C., Brown, J. T., Sharkey, W. K., Walls, A. C., Joshi, A., Sprouse, K. R., McCallum, M., Tortorici, M. A., et al. (2022) · Science Immunology · doi:10.1126/sciimmunol.adf1421 · Cited by 81
Advances in the design and development of SARS-CoV-2 vaccines
Peng, X., Cheng, J., Gong, H., Yuan, M.-D., Zhao, X., Li, Z., & Wei, D. (2021) · Military Medical Research · doi:10.1186/s40779-021-00360-1 · Cited by 84
Case, J. B., Chen, R. E., Cao, L., Ying, B., Winkler, E. S., Johnson, M., Goreshnik, I., Pham, M. N., Shrihari, S., Kafai, N. M., et al. (2021) · Cell Host & Microbe · doi:10.1016/j.chom.2021.06.008 · Cited by 73
Megremis, S., Walker, T. D. J., He, X. T., Ollier, W., Chinoy, H., Hampson, L., HAMPSON, I. N., & Lamb, J. A. (2020) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2020-217522 · Cited by 76
Baker, D., Amor, S., Kang, A. S., Schmierer, K., & Giovannoni, G. (2020) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2020.102174 · Cited by 75
Metadata
- Authors
- Letko, M., Marzi, A., & Munster, V.
- Affiliations
- National Institutes of Health (US)
- National Institute of Allergy and Infectious Diseases (US)
- Corresponding author
- Letko, Michael
- Munster, Vincent
- Venue
- Nature Microbiology
- Published
- 2020-02-24
- Volume
- 5
- Issue
- 4
- Pages
- 562-569
- ISSN
- 2058-5276 (ISSN-L)
- PMC
- PMC7095430
- OpenAlex
- W3008394341
- Cited by
- 3,109
- References
- 38
- Citations by year
- 2026: 47 · 2025: 122 · 2024: 198 · 2023: 287 · 2022: 571 · 2021: 874 · 2020: 1002
- FWCI
- 89.66
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Nature Microbiology (publishedVersion)
- bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (submittedVersion)
- Funders
- Chinese Center for Disease Control and Prevention
- Chinese Academy of Medical Sciences
- Peking Union Medical College
- National Institute of Allergy and Infectious Diseases
- Topics
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
- Life Sciences › Agricultural and Biological Sciences › Animal Science and Zoology › Animal Virus Infections Studies
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Zoonotic diseases and public health
- Keywords
- SARS-CoV-2, SARS-CoV, cell entry, ACE2 receptor, zoonotic transmission, viral recombination, cross-species infection
- MeSH terms
- Protein Domains, Betacoronavirus, Receptors, Coronavirus, Angiotensin-Converting Enzyme 2, COVID-19, SARS-CoV-2, Animals, Cell Line, Humans, Peptidyl-Dipeptidase A, Mutation, Pneumonia, Viral, Receptors, Virus, Recombinant Fusion Proteins, Trypsin, Coronavirus Infections, Dipeptidyl Peptidase 4, CD13 Antigens, Severe acute respiratory syndrome-related coronavirus, Virus Internalization, Pandemics, Spike Glycoprotein, Coronavirus
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
